Global Alpha Capital Management Ltd. Has $66.62 Million Holdings in RadNet, Inc. (NASDAQ:RDNT)

Global Alpha Capital Management Ltd. reduced its position in shares of RadNet, Inc. (NASDAQ:RDNT) by 3.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 960,034 shares of the medical research company’s stock after selling 34,100 shares during the quarter. RadNet accounts for approximately 4.3% of Global Alpha Capital Management Ltd.’s holdings, making the stock its 3rd biggest position. Global Alpha Capital Management Ltd. owned about 1.30% of RadNet worth $66,617,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. AQR Capital Management LLC grew its stake in shares of RadNet by 3.2% during the 2nd quarter. AQR Capital Management LLC now owns 5,131 shares of the medical research company’s stock valued at $302,000 after acquiring an additional 160 shares during the period. Chartwell Investment Partners LLC grew its stake in shares of RadNet by 0.8% during the 3rd quarter. Chartwell Investment Partners LLC now owns 24,883 shares of the medical research company’s stock valued at $1,726,000 after acquiring an additional 193 shares during the period. SG Americas Securities LLC boosted its stake in RadNet by 8.7% in the 1st quarter. SG Americas Securities LLC now owns 3,637 shares of the medical research company’s stock worth $177,000 after purchasing an additional 291 shares during the period. Crossmark Global Holdings Inc. boosted its stake in RadNet by 6.3% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 4,958 shares of the medical research company’s stock worth $344,000 after purchasing an additional 296 shares during the period. Finally, Hanseatic Management Services Inc. boosted its stake in RadNet by 1.8% in the 2nd quarter. Hanseatic Management Services Inc. now owns 19,968 shares of the medical research company’s stock worth $1,177,000 after purchasing an additional 353 shares during the period. 77.90% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have weighed in on RDNT shares. Barclays upgraded RadNet from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $57.00 to $79.00 in a research note on Friday, September 6th. Sidoti upgraded RadNet to a “strong-buy” rating in a research note on Friday, October 4th. Truist Financial upped their price target on RadNet from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, September 23rd. Finally, Jefferies Financial Group upped their price target on RadNet from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, September 19th. One research analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $74.75.

RadNet Stock Performance

NASDAQ:RDNT opened at $79.85 on Wednesday. The stock’s fifty day moving average is $69.65 and its 200 day moving average is $63.37. RadNet, Inc. has a fifty-two week low of $31.55 and a fifty-two week high of $93.65. The firm has a market capitalization of $5.91 billion, a PE ratio of -1,140.55 and a beta of 1.75. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.16 and a current ratio of 2.16.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.